Prof. Dr. Bart N. Lambrecht is a leading expert in pulmonary medicine, asthma, allergy, and respiratory infections. His research has significantly advanced our understanding of lung immunity, shaping new treatment strategies for respiratory diseases.

He earned his MD and PhD in Medicine at Ghent University (UGent) and specialized in Pulmonary Medicine at Erasmus University Medical Center in Rotterdam. Today, he is Professor of Pulmonary Medicine at both ErasmusMC and UGent and Director of the VIB Inflammation Research Center, where he leads 400 scientists.

He is a multiple ERC grant awardee, has authored over 400 scientific papers, and serves on the editorial boards of Trends in Immunology and the Journal of Experimental Medicine. Together with Prof. Hamida Hammad, he leads a 36-member research unit, focusing on antigen-presenting cells (APCs) in asthma and respiratory infections. Their work has advanced the scientific understanding of how dendritic cells, macrophages, and epithelial cells drive immune responses in the lung.

By collaborating with biotech and pharma, he actively drives breakthroughs from the lab to the clinic, advocating that scientific discoveries reach patients. Since the COVID-19 pandemic, he has led large multi-center trials investigating novel immunotherapies, advancing the fight against respiratory diseases.